These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2871298)

  • 1. Secondary leukaemia in Hodgkin's disease.
    Selby P; Horwich A
    Lancet; 1986 May; 1(8488):1027-8. PubMed ID: 2871298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute myeloid leukemia during Hodgkin's disease].
    Dziewulska-Bokiniec A; Jassem J
    Acta Haematol Pol; 1979; 10(2):137-40. PubMed ID: 289273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease terminating as acute leukaemia: case report and review of the literature.
    Wakem CJ; Bennett JM
    N Z Med J; 1972 Sep; 76(484):187-94. PubMed ID: 4508745
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there an association between total-body irradiation and secondary acute myelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation?
    Fung HC; Nademanee AP; Bhatia S; Forman SJ
    J Clin Oncol; 2001 Aug; 19(15):3585-8. PubMed ID: 11481369
    [No Abstract]   [Full Text] [Related]  

  • 6. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 8. Second malignant lesions after therapy for Hodgkin's disease.
    Schomberg PJ; Evans RG; Banks PM; White WL; O'Connell MJ; Earle JD
    Mayo Clin Proc; 1984 Jul; 59(7):493-7. PubMed ID: 6588280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
    Glicksman AS; Pajak TF; Gottlieb A; Nissen N; Stutzman L; Cooper MR
    Cancer Treat Rep; 1982 Apr; 66(4):1035-44. PubMed ID: 6951632
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningioma-like cerebral relapse of Hodgkin's disease.
    Montillo M; Scarpelli M; Discepoli G; Catarini M; Rychlicki F; Leoni P
    Leuk Lymphoma; 1994 Jun; 14(1-2):185-7. PubMed ID: 7920227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of terminal leukemia in a patient with Hodgkin's disease].
    Quaglino D; Emilia G; Di Prisco AU; De Pasquale A; Zagni G
    Minerva Med; 1975 Feb; 66(15):689-98. PubMed ID: 1054112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second malignacies complicating Hodgkin's disease. 1 case].
    Blanc AP; Gastaut JA; Carcassonne Y
    Sem Hop; 1979 Jan 8-15; 55(1-2):80-2. PubMed ID: 218300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
    de Gramont A; Rioux E; Drolet Y; Delage JM
    Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease.
    Hoppe RT
    Leukemia; 1992 Nov; 6 Suppl 4():155-7. PubMed ID: 1434819
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
    Lavey RS
    J Clin Oncol; 1990 Dec; 8(12):2089-90. PubMed ID: 2230901
    [No Abstract]   [Full Text] [Related]  

  • 17. Hodgkin's disease terminating in acute leukaemia: report of seven cases.
    Wolf MM; Cooper IA; Ding JC
    Aust N Z J Med; 1979 Aug; 9(4):398-402. PubMed ID: 292379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of secondary neoplasms in Hodgkin's disease as sequelae of oncologic therapy].
    Hartmann D
    Schweiz Rundsch Med Prax; 1984 Jan; 73(4):95-8. PubMed ID: 6583794
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
    Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
    J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of new cancers in patients with Hodgkin's disease.
    Arseneau JC; Canellos GP; Johnson R; DeVita VT
    Cancer; 1977 Oct; 40(4 Suppl):1912-6. PubMed ID: 907993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.